Literature DB >> 147105

Studies on the ATPase complex from beef-heart mitochondria. I. Isolation and characterization of an oligomycin-sensitive and an olgiomycin-insensitive ATPase complex from beef-heart mitochondria.

J A Berden, M M Voorn-Brouwer.   

Abstract

1. A new method for the isolation of the oliogomycin-sensitive ATPase from beef-heart mitochondria is described. 2. A Triton-soluble ATPase complex was isolated as a by-product of the standard procedure, or as the main product when the submitochondrial particles were pretreated with 1% Triton. The ATPase activity of this complex is sensitive neither to oligomycin nor to dicyclohexylcarbodiimide. 3. The ATPase activity of the oligomycin-sensitive ATPase complex is nearly completely dependent on added phospholipids. The highest activation was found with asolectin. 4. The oligomycin-sensitive complex can be integrated into phospholipid vesicles resulting in an ATP- and Mg2+-dependent energization of the vesicles as monitored with the fluorescent dye 9-amino-6-chloro-2-methoxyacridine. 5. Aurovertin-binding studies based on fluorescence measurement reveal the presence of 1.5 mumol aurovertin-binding sites per g protein for the oligomycin-sensitive complex and about 2.2 mumol for the oligomycin-insensitive complex. 6. The preparation of the oligomycin-sensitive complex contains at least 6--7 polypeptides in addition to those derived from F1. One of these polypeptides, with an apparent molecular weight of 31 000, is virtually absent from the oligomycin-insensitive complex. 7. Some of these polypeptides have been identified and isolated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 147105     DOI: 10.1016/0005-2728(78)90110-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Structure and function of H+-ATPase.

Authors:  Y Kagawa; N Sone; H Hirata; M Yoshida
Journal:  J Bioenerg Biomembr       Date:  1979-08       Impact factor: 2.945

Review 2.  Bacterial adenosine 5'-triphosphate synthase (F1F0): purification and reconstitution of F0 complexes and biochemical and functional characterization of their subunits.

Authors:  E Schneider; K Altendorf
Journal:  Microbiol Rev       Date:  1987-12

3.  F1F0-ATP synthase from bovine heart mitochondria: development of the purification of a monodisperse oligomycin-sensitive ATPase.

Authors:  R Lutter; M Saraste; H S van Walraven; M J Runswick; M Finel; J F Deatherage; J E Walker
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

Review 4.  Structure and function of the membrane-integral components of the mitochondrial H+-ATPase.

Authors:  J Houstĕk; J Kopecký; P Svoboda; Z Drahota
Journal:  J Bioenerg Biomembr       Date:  1982-02       Impact factor: 2.945

5.  Isolation of a highly active H+-ATPase from beef heart mitochondria.

Authors:  J Hughes; S Joshi; K Torok; D R Sanadi
Journal:  J Bioenerg Biomembr       Date:  1982-12       Impact factor: 2.945

6.  Solubilization and partial purification of n,n'-dicyclohexylcarbodiimide-sensitive ATPase from pea cotyledon mitochondria.

Authors:  M B Whisson; M S Spencer
Journal:  Plant Physiol       Date:  1983-04       Impact factor: 8.340

7.  Phospholipid association with the bovine cardiac mitochondrial adenosine triphosphatase.

Authors:  R E Brown; R I Montgomery; P I Spach; C C Cunningham
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

8.  Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin.

Authors:  Kathryn M Johnson; Lara Swenson; Anthony W Opipari; Rolf Reuter; Nawid Zarrabi; Carol A Fierke; Michael Börsch; Gary D Glick
Journal:  Biopolymers       Date:  2009-10       Impact factor: 2.505

9.  Electrophoretic behavior of the H+-ATPase proteolipid from bovine heart mitochondria.

Authors:  J Kopecký; J Houstĕk; E Szarska; Z Drahota
Journal:  J Bioenerg Biomembr       Date:  1986-12       Impact factor: 2.945

10.  Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils.

Authors:  H Carp
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.